DiA Imaging Analysis News
36 articles
growth-positive
With its built-in AI interface, Dia hopes to give people an easy way to use AI, cutting out the need to visit tools like ChatGPT, Perplexity, and Claude.
The Browser Company is shifting its focus from its previous web browser, Arc, to a new AI-integrated browser called Dia. Recognizing the growing importance of AI in web tools, Dia is designed to incorporate AI at its core, offering users an AI interface directly within the browser. This allows users to perform tasks like web searches, file summarization, and drafting documents using AI. The browser is currently in beta and available by invite. Dia aims to streamline the user experience by integrating AI functionalities that eliminate the need for separate AI tools. The browser is based on Chromium, providing a familiar interface while introducing innovative features like customizable chatbots and coding shortcuts.
Product Stage
growth-positive
סטארט-אפ מבאר שבע של שתי נשים עושה מהפכה באבחון בעיות לב
DiA Imaging Analysis, an Israeli startup founded by Hila Goldman-Aslan and Michal Yaakobi, has developed an AI-based technology for rapid and accurate heart problem diagnosis. The company was acquired by Philips for tens of millions of dollars in May of the previous year. Despite challenges in Israel, including war and legal upheavals, DiA has continued to thrive, with significant support from global investors. The technology, already FDA-approved, is integrated into Philips ultrasound devices, enhancing cardiology diagnostics worldwide. Philips acquisition strategy involved initial commercial agreements and investments, recognizing DiAs scalable technology. The acquisition underscores Philips commitment to leveraging Israeli innovation in medical technology.
Acquired-by
growth-positive
Philips buys Israeli co DiA Imaging Analysis
Philips Healthcare Imaging is acquiring DiA Imaging Analysis, an Israeli company that has developed AI-powered software for improving heart ultrasound imaging analysis. DiA has nine FDA approvals and generates annual revenue of several million dollars. Philips is paying slightly under $100 million for the acquisition. DiA was founded in 2009 and has raised $25 million to date. The acquisition is seen as a good match and a strategic decision for Philips.
Acquisition
growth-positive
DiA Secures FDA Clearance for New AI-Powered Software, Assisting Ultrasound Users To Capture High-Quality Images
DiA Imaging Analysis has received FDA clearance for its LVivo IQS software, an AI-based vendor-neutral solution that provides real-time image quality feedback for cardiac ultrasound users. The software uses colors and numerical scoring to indicate the quality level of the image as it is being scanned, helping users produce optimal interpretable images for more accurate analysis of the heart. The clearance follows a clinical study that demonstrated the safety and efficacy of LVivo IQS. The software is part of DiAs suite of AI solutions aimed at overcoming challenges in ultrasound image capture and analysis. DiA Imaging Analysis will showcase its software suite at the American College of Cardiology Annual Scientific Session & Expo.
Customers
growth-positive
ScImage and DiA Imaging Analysis Team Up to Infuse AI into Echocardiography Labs
ScImage Inc. and DiA Imaging Analysis have announced a commercial partnership to combine ScImages Cloud architecture with DiAs AI-based cardiac ultrasound software. This partnership aims to provide echo labs with greater access to innovative healthcare imaging technology, improving workflow efficiency and patient care. ScImages Cloud-centric platform, PICOM365, will integrate with DiAs LVivo Seamless software to offer quantitative image analysis and longitudinal measurement accuracy. DiAs AI-based algorithms will automatically select and analyze optimal cardiac ultrasound images, generating key clinical indications for echo studies. The results will be inserted into PICOM365 structured reports, enhancing the echo lab workflow. The partnership between ScImage and DiA will make their solutions accessible to more echocardiologists and imaging specialists worldwide.
Partners
growth-positive
DiA Imaging Analysis Teams up with Healthcare Technology Company to Expand its AI Offering for Echo-lab Cardiac Exams
DiA Imaging Analysis has announced a multi-year agreement with Change Healthcare to integrate its AI-based ultrasound analysis software into Change Healthcares imaging solutions. The partnership aims to improve the efficiency of routine tasks and workflow in the Echo Lab reading environment, benefiting echocardiologists and other imaging specialists. DiAs FDA-cleared and CE-marked LVivo Seamless™ solution will be available on Change Healthcares imaging solutions. The AI-based software automates the workflow and provides objective analysis of cardiac ultrasound images, generating key clinical indications for review. The partnership is expected to positively impact patient outcomes and care.
Partners
growth-positive
DiA Imaging Analysis adds $14 million in funding for its AI ultrasound solution
DiA Imaging Analysis, an Israeli company that provides AI-driven ultrasound analysis, has completed a $14 million investment, bringing its total amount to $25 million. The investment will help the company expand its portfolio of solutions and pursue new partnerships with ultrasound vendors. Dr. Diku Mandavia has joined the companys Board of Directors. DiAs technology uses AI to detect borders and motion in ultrasound images, improving clinical assessments. The companys LVivi Toolbox is currently used in over 20 countries. DiA has partnered with technology providers and distributors including IBM Watson, GE Healthcare, Konica Minolta, and Philips.
InvestmentPartners
growth-positive
Circle Cardiovascular Imaging Announces Partnership with DiA Imaging Analysis to Deliver All-in-One Comprehensive AI-Based Cardiovascular Imaging Solutions
Circle Cardiovascular Imaging Inc. and DiA Imaging Analysis Ltd. have announced a multi-year partnership to leverage their synergies in cardiac AI and data analytics. Circle CVI, a global leader in cardiovascular imaging reading and reporting, has expanded its product offering by adding DiAs AI-based cardiac ultrasound solutions. This collaboration will provide expanded imaging solutions to Circle CVIs customers and new opportunities for physicians, patients, and hospitals worldwide. The partnership is expected to accelerate the deployment of DiAs advanced ultrasound solutions and improve patient outcomes. The companies solutions are vendor-neutral and can integrate into any hospital or enterprise site. DiA will showcase its AI-enabled solutions at an upcoming virtual event. Circle CVIs imaging platform, cvi42, is widely used in over 1,000 hospitals and more than 50 countries.
Partners
growth-positive
DiA Imaging Analysis Partners with SonoScape Medical Corporation to Deliver Cardiac Ultrasound AI solutions
DiA Imaging Analysis has partnered with SonoScape Medical Corporation to provide AI-powered ultrasound analysis solutions. The partnership aims to reduce variability in manual or visual analysis and increase efficiency and accuracy. The partnership addresses the growing need for objective and accurate analysis in the ultrasound market. SonoScapes ultrasound devices will incorporate DiAs AI technology to enable automated analysis and identification of clinical abnormalities. DiAs AI solutions, LVivo Toolbox™, imitate the human eyes ability to detect borders and identify motion. The partnership is expected to make ultrasound image analysis smarter and more accessible.
Partners
growth-positive
DiA Imaging Analysis partners with Philips to enhance ultrasound with AI-based image quantification
DiA Imaging Analysis has announced a strategic partnership with Royal Philips to deliver automated solutions to clinicians at the point-of-care. The partnership aims to increase diagnostic confidence, operational efficiency, and access to care for Point-of-Care customers. DiAs AI-powered solutions combined with Philips ultrasound image quality will be deployed on Philips Ultrasound devices. DiA will showcase its AI-enabled solutions at the European Congress of Radiology 2021 virtual event. DiA Imaging Analysis is a leading provider of AI-powered ultrasound analysis solutions.
Partners
growth-positive
Konica Minolta and DiA Expand AI-based Echocardiography Analysis and Reporting on Exa® Cardio PACS Platform
Konica Minolta Healthcare Americas, Inc. and DiA Imaging Analysis Ltd. have expanded the deployment of the LVivo Cardiac ultrasound AI Toolbox on the Exa Cardio PACS platform. This allows Exa users to perform automated and quantified analysis of the left ventricle to detect cardiac dysfunction in COVID-19 patients. The LVivo EF solution can be used to monitor COVID-19 patients global heart function on any workstation, reducing patient imaging bottlenecks and minimizing patient-staff contact. The LVivo AI-based Cardiac Toolbox is accessible in one click and helps automate workflow and increase efficiency in echocardiography analysis. The partnership between Konica Minolta and DiA Imaging Analysis aims to provide reliable and fast measurements based on echocardiograms, supporting clinicians decision-making process.
CustomersPartners
growth-positive
DiA Granted FDA Clearance for its Cardiac Ultrasound AI Auto Views Selection
DiA Imaging Analysis has received FDA clearance for the commercial use of LVivo Seamless, an AI-powered solution that automatically selects optimal cardiac ultrasound views. The software operates without human touch and provides rapid, reliable, and accurate view selections and measurements. The solution integrates with DiAs other products, such as LVivo EF, which automates the calculation of ejection fraction. DiAs ultrasound AI solutions are cross-platform and vendor-neutral, allowing them to run on images from any ultrasound device. The company aims to reduce variability in view selection and analysis of cardiac ultrasound images. DiA Imaging Analysis is a leading provider of AI-powered ultrasound analysis solutions.
Customers
growth-positive
DiA Secures FDA Clearance and CE Mark for Additional AI-Based Ultrasound Analysis Solutions for Use on the COVID-19 Frontlines
DiA Imaging Analysis has received FDA clearance and a European CE mark for two additional AI-powered ultrasound analysis solutions. The first solution, LVivo RV, is an AI-based automated analysis of the hearts right ventricle and can be used to diagnose and monitor right heart ailments, including those with COVID-19. The second solution, LVivo Bladder, uses AI to deliver automated bladder volume measurements on ultrasound devices. These solutions join DiAs existing LVivo Toolbox of AI-powered ultrasound solutions. The company aims to make ultrasound analysis smarter and more accessible across a broader range of healthcare segments. The article highlights the growing evidence linking COVID-19 mortality and right ventricle heart failure, emphasizing the importance of AI-powered solutions in cardiac ultrasound.
Customers
growth-positive
Medical Analytics Company DiA Aims to Detect Heart Complications in Coronavirus Patients
Israel-based medical analytics company DiA Imaging Analysis Ltd. has received a grant of NIS 2.5 million ($710,000) from the Israel Innovation Authority (IIA) to develop AI-based technology for deciphering ultrasound imaging of COVID-19 patients. The grant will enable quick access to DiAs technologies and the development of additional solutions to monitor patients progress by ultrasound. DiA develops pattern recognition and machine learning software for automated image analysis in ultrasound devices and medical picture archiving and communication systems (PACS).
Investment
growth-positive
DiA Imaging Analysis Receives Grant to Accelerate Global Access to its AI Ultrasound Solutions in the Fight Against COVID-19
DiA Imaging Analysis has received a government grant from the Israel Innovation Authority (IIA) to develop AI solutions for ultrasound imaging analysis of COVID-19 patients. The grant provides a budget of millions NIS to increase access to DiAs solutions globally and accelerate R&D for new AI solutions for COVID-19 patient management. DiAs AI-based technology aims to make ultrasound analysis smarter and accessible to both new and expert users. The companys LVivo Cardio Toolbox enables clinicians to automatically generate objective clinical analysis for cardiac ultrasound. DiA has received FDA/CE clearances and established distribution partnerships with companies like GE Healthcare and IBM Watson.
InvestmentPartners
growth-positive
DiA cardiac ultrasound solution selected for IBM's AI imaging marketplace
DiA Imaging Analysis Ltd. has announced that its AI-powered cardiac ultrasound software is available on the new IBM Imaging AI Marketplace. The software, called LVivo EF, uses AI to measure ejection fraction in cardiac ultrasound and replaces visual estimation. The solution is used in echocardiography labs and in mobile, point-of-care ultrasound. DiA Imaging Analysis Ltd. has also partnered with GE Healthcare for their Vscan Extend handheld mobile ultrasound. The partnership with IBM provides a curated marketplace for customers to choose from vetted AI imaging solutions. The marketplace aims to help hospitals make informed decisions about adding AI solutions to their facilities.
Partners
growth-positive
Israeli AI Medical Imaging Startup DiA Partners With IBM Watson Health
Israeli AI medical imaging startup DiA Imaging Analysis has partnered with IBM Watson Health to offer its AI-powered cardiac ultrasound software on IBMs Imaging AI Marketplace. The software is designed to assist clinicians in automatically analyzing cardiac ultrasound images. DiAs LVivo EF solution, which offers AI-powered quantification of data such as Ejection Fraction and Global Longitudinal Strain, will also be introduced on the Marketplace. The collaboration aims to make ultrasound analysis smarter and more accessible to clinicians with various levels of experience.
Partners
growth-positive
DiA Imaging Analysis partnered with Edan Instruments to accelerate the adoption of DiA's AI-based cardiac ultrasound solutions
DiA Imaging Analysis Ltd. announced a partnership with Edan Instruments Inc., a leading medical products and services company. The partnership aims to offer Edans customers an additional layer of automated AI-based analysis for cardiac ultrasound. DiAs AI-based cardiac solution, LVivo Toolbox, provides fast and objective ultrasound analysis, reducing subjectivity and increasing efficiency for clinicians. Edan Instruments has developed unique ultrasound devices that offer advanced imaging technologies. DiAs CEO will be speaking about the future of AI in cardiac ultrasound at an upcoming conference.
Partners
growth-positive
Terason Partners With DiA Imaging Analysis to Bring Superior AI Cardiac Solutions to Point-of-care Ultrasound
Terason, a global ultrasound imaging company, has partnered with DiA Imaging Analysis to provide cardiac solutions on Terasons point-of-care ultrasound devices. The partnership aims to offer more accurate and objective image analysis for clinicians in hospitals and outpatient settings. DiAs AI-based technology will identify cardiac functions and abnormalities, generating fast and objective results. Terasons CEO states that the partnership will provide superior solutions for managing patients with heart failure or cardiovascular disease. Terason is a market leader in ultrasound-guided venous intervention and has produced portable ultrasound systems since 2000. DiA Imaging Analysis is a leading provider of AI-powered ultrasound analysis solutions. The partnership is a growth-positive development for Terason.
Partners
growth-positive
Konica Minolta Healthcare partners with DiA Imaging Analysis to offer advanced AI-based cardiac ultrasound analysis
DiA Imaging Analysis has partnered with Konica Minolta Healthcare Americas Inc. to expand analysis capabilities of Konica Minoltas Exa Cardio PACS Platform with DiAs cardiac analysis, LVivo Toolbox. The LVivo Cardiac Toolbox uses AI-powered algorithms to automatically analyze cardiac ultrasound images, providing fast and accurate image analysis to support clinicians decision-making process. The partnership allows Konica Minolta to offer clinicians decision support with objective data and integrate AI-based cardiac analysis into their structured reporting system. DiAs CEO and Co-Founder, Hila Goldman Aslan, expressed excitement about the partnership and the opportunity to provide valuable insights into cardiac function analysis for Konica Minoltas users.
Partners
growth-positive
"New Studies Suggest That DiA's AI-based Software, LVivo EF, Is Accurate and Efficient in Assessing Ejection Fraction Values Compared to Cardiac MRI and Contrast Echocardiography "
DiA Imaging Analysis has presented two studies validating the performance and accuracy of their AI-based solution, LVivo EF, for assessing Left Ventricular Ejection Fraction. The solution has the potential to provide accurate and objective quantification of LV EF, saving time and resources for clinicians. The studys findings show that LVivo EF can be used at the patients bedside, particularly in patients with low EF. The solution also facilitates immediate confirmation of accuracy by providing an endocardial border overlay on moving images.
Customers
growth-positive
Ebit and DiA Imaging Analysis Partner on AI-based Cardiac Ultrasound Analysis
Ebit has entered into a partnership agreement with DiA to bring DiAs LVivo Toolbox for echo analysis and reporting to Ebits Suitestensa CVIS. The partnership aims to benefit cardiovascular practices.
Partners
growth-positive
DiA Imaging Analysis Introduces LVivo SAX Ultrasound Analysis Tool
Philips, a leader in cardiovascular ultrasound, will showcase its AI technology LVivo SAX, which uses artificial intelligence to identify abnormalities in heart function and assist in detecting heart attacks. The AI algorithm has high diagnostic accuracy and has been accepted for publication in the American Journal of Roentgenology. The article highlights the Top 10 most-read pieces of content from itnonline.com, indicating the interest in AI technology in the medical field. The event described in the article is the showcasing of Philips AI technology in cardiovascular ultrasound. The date of the event is June 23, 2023.
CustomersPartners
growth-positive
Ebit (Esaote Group) and DiA Imaging Analysis have partnered offering Advanced AI-based Cardiac Ultrasound Analysis
DiA Imaging Analysis has partnered with the Italian healthcare IT company Ebit to offer DiAs LVivo Cardiac Toolbox as part of Ebits SUITESTENSA CVIS PACS. The partnership aims to improve patient outcomes by providing healthcare providers with advanced AI-based cardiac analysis tools. The LVivo Cardiac Toolbox uses pattern recognition and machine learning algorithms to analyze cardiac ultrasound images objectively and reproducibly. The integration of the toolbox into Ebits PACS viewer will make AI analysis accessible to all lab users and enhance the efficiency of the decision-making process. Ebits Suitestensa CVIS PACS is a vendor-neutral platform that allows physicians to manage and share data reports and clinical images produced by any cardiological equipment. The partnership between DiA and Ebit expands the boundaries of Ebits system and offers better patient care.
Partners
growth-positive
DiA Imaging Analysis' AI-Powered LVivo EF Cardiac Tool Now Available for the GE Healthcare Vscan Extend™ Handheld Mobile Ultrasound
DiA Imaging Analysis announced that its LVivo EF cardiac decision-support software is now available for purchase for GEs new Vscan Extend handheld ultrasound. This collaboration with GE Healthcare is expected to transform point-of-care ultrasound to a more consistent and patient-centered process. LVivo EF is the first AI-powered app that can operate in low-memory and processing-power environments. It provides clinicians with left ventricle EF scoring and volume measurements, addressing the challenge of achieving accurate EF results in point-of-care settings. The LVivo EF app is part of DiAs cardiac toolbox, and the company offers additional cardiac ultrasound decision-support apps. DiA is exhibiting at the American College of Emergency Physicians Scientific Assembly in October.
Partners
growth-positive
Dia Imaging Analysis raises $5 million for AI that analyzes ultrasound scans
Dia Imaging Analysis, an AI health care startup that develops automation tools for ultrasound scanners, has announced a $5 million funding round. The funding will be used to extend its portfolio, grow its team, and build support teams in the U.S., Europe, and Asia. Dias software solution uses proprietary machine learning algorithms to analyze scans and detect patterns in real time. The companys first product, which performs echocardiography, has been cleared by the FDA and European health regulators. Dia has also signed licensing and collaborative agreements with GE Health, Google Cloud, and Neusoft Medical Systems. The companys investors include Connecticut Innovations, Defta Healthcare, the Israeli government’s Innovation Authority, Shengjing group, AltaIR Capital, and CE Ventures.
InvestmentExpand
growth-positive
DiA Imaging Analysis inks deal with Google Cloud
DiA Imaging Analysis has signed a collaboration agreement with Google Cloud to commercialize new automated ultrasound imaging analysis software. The technology will provide automated image quantification and analysis through the Google Cloud Platform for immediate and remote image evaluation. The offerings can be implemented with any ultrasound device and any healthcare IT system, all as part of the physicians workflow.
Partners
growth-positive
Israeli startup partners with GE to help patients get quicker ultrasound reads
GE Healthcare has signed a multi-year agreement with DiA Imaging Analysis to incorporate the startups automated imaging technology into its ultrasound devices. DiAs software uses advanced pattern recognition and machine learning algorithms to provide quick and accurate interpretations of ultrasound images. The technology is designed for point-of-care settings, allowing medical professionals to make quick diagnoses using smaller or handheld ultrasound devices. DiAs first product, cardiac ultrasound software, has received regulatory approvals and the company plans to launch additional automated imaging analysis tools. GE Healthcare has been seeking innovative technologies and has recently partnered with Israeli startups. DiA has raised $2.75 million in funding to date from investors including Chinas Shengjing group, AltaIR Capital, and CE Ventures.
Partners
N/A
Israel-based DiA Imaging inks deal with GE Healthcare on ultrasound devices
The article discusses the terms of use and privacy policy of Questex LLC.
growth-positive
DiA Imaging Analysis teams with GE Healthcare
DiA Imaging Analysis has signed a licensing and professional services agreement with GE Healthcare to develop its automated imaging analysis technology for GE Healthcares ultrasound devices. The partnership aims to improve patient care by providing immediate, accurate, and reproducible imaging interpretation of ultrasound in point of care settings. DiA is the only company currently offering automated tools for handheld ultrasound devices.
Partners
growth-positive
DiA Imaging Analysis Enters Partnership with GE Healthcare on Automatic Imaging Analysis Tools
DiA Imaging Analysis has signed a multi-year, non-exclusive licensing and professional services agreement with GE Healthcare to develop its automated imaging analysis technology for use with GE Healthcares ultrasound devices. The partnership aims to improve monitoring of patient conditions and provide physicians with powerful tools to support their decisions. DiA Imaging Analysis is the only company currently offering automated tools for handheld ultrasound devices. The company plans to launch additional automated imaging analysis tools in the future. The partnership was announced on November 20, 2017.
Partners
growth-positive
Neusoft Medical Systems Partners with DiA Imaging Analysis to Bring Breakthrough Cardiac Automated Tools to its Ultrasound Product Line
Neusoft Medical Systems has signed a partnership agreement with DiA Imaging Analysis to integrate DiAs automated software tools into its ultrasound line of products. This partnership will provide Neusofts customers with quick and accurate imaging analysis of the heart, improving patient care and physician workflow. The advanced product capabilities will be available to all Neusoft customers. The collaboration marks a significant milestone for DiA in establishing a strong presence in China. Neusoft Medical Systems is a leading developer and manufacturer of advanced medical equipment in China, while DiA Imaging Analysis is a medical imaging analysis software company.
Partners
growth-positive
CDN joins forces with DiA Imaging Analysis
Australian RIS/PACS vendor Central Data Networks (CDN) has signed a partnership agreement with echocardiography image analysis software developer DiA Imaging Analysis. CDN has integrated DiAs automated software applications into its CardioMotion cloud-based image management suite.
Partners
growth-positive
DIA Imaging Analysis Ltd is the New Name of DiACardio, Expanding its Vision in Medical Imaging
DiACardio, makers of next generation imaging analysis technology, has changed its name to DiA Imaging Analysis. The name change reflects the companys expansion into a broader set of medical imaging analysis solutions. DiA has received FDA and CE clearances for two additional cardio imaging analysis solutions and has been recognized for its innovation in the field. The company plans to accelerate the development of its cardio toolbox and expand into additional segments. DiA is a medical imaging analysis software company based in Israel, with a presence in the US. The company is led by experienced entrepreneurs and supported by key opinion leaders in the medical field.
Expand
growth-positive
DiACardio Named Venture+ Forum Pitch Competition Winner At HIMSS17
DiACardio Ltd. has been announced as the winner of the Venture+ Forum pitch competition at the 2017 HIMSS Annual Conference & Exhibition. The company has developed an image processing technology that uses pattern recognition and machine learning algorithms to automatically mark and track parameters in medical images. Their initial focus is on ultrasound images of the heart. The technology has obtained FDA and CE approval and offers healthcare providers a faster, easier, and more accurate tool for diagnosing and treating patients. The Venture+ Forum provides a platform for startups to connect with healthcare providers, investors, and strategic partners. DiACardios win at the competition signifies growth-positive impact for the company.
Partners
growth-positive
DiACardio wins Shengjing Global Innovation Awards
Israeli startup DiACardio has won first place in the Shengjing Global Innovation Awards 2015, a global startup competition held in China. The company developed a software to decode echocardiograms. Winning the competition opens up investment opportunities for DiACardio, and the company believes it will advance the recognition of their technology. The top five startups in the competition will share $1 million in cash prizes. DiACardios CEO, Hila Goldman-Aslan, expressed excitement and pride in winning first place. The finalists will now have the opportunity to meet with Chinese internet giants Alibaba, Tencent, Baidu, JD.com, and Xiaomi.
Investment
